Abstract
Although most infantile haemangiomas do not require treatment due to a natural history of spontaneous involution, some require early intervention. The Australasian Vascular Anomalies Network and the Australasian Paediatric Dermatology Network have developed a consensus statement for the treatment of infantile haemangiomas with oral propranolol. Infants with haemangiomas that are life threatening, at risk of ulceration, or at risk of causing a significant functional impairment, psychological impact or physical deformity should be treated early with oral propranolol. Oral propranolol is safe and effective and in most healthy infants oral propranolol can be started in an outpatient setting.
| Original language | English |
|---|---|
| Pages (from-to) | 155-159 |
| Number of pages | 5 |
| Journal | Australasian Journal of Dermatology |
| Volume | 58 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - May 2017 |
| Externally published | Yes |
Keywords
- Australian
- beta-blocker
- consensus
- hemangioma
- infantile haemangioma
- New Zealand
- propranolol
- vascular anomaly
Cite this
}
Consensus statement for the treatment of infantile haemangiomas with propranolol. / Smithson, Sarah L.; Rademaker, Marius ; Adams, Susan; Bade, Stuart; Bekhor, Philip; Davidson, Samantha; Dore, Amanda; Drummond, Catherine; Fischer, Gayle; Gin, Alexander; Grills, Claire; Halbert, Anne; Lokmic, Zerina; McCahon, Emma; Morgan, Vanessa A.; Murrell, Dedee F; Orchard, David; Penington, Anthony; Purvis, Diana; Relic, John; Robertson, Susan; Robinson, Aaron J.; Scardamaglia, Laura; Su, John; Tan, Swee; Wargon, Orli; Warren, Lachlan; Wong, Li Chuen; Zappala, Tania; Phillips, Roderic.
In: Australasian Journal of Dermatology, Vol. 58, No. 2, 05.2017, p. 155-159.Research output: Contribution to journal › Article › Other › peer-review
TY - JOUR
T1 - Consensus statement for the treatment of infantile haemangiomas with propranolol
AU - Smithson, Sarah L.
AU - Rademaker, Marius
AU - Adams, Susan
AU - Bade, Stuart
AU - Bekhor, Philip
AU - Davidson, Samantha
AU - Dore, Amanda
AU - Drummond, Catherine
AU - Fischer, Gayle
AU - Gin, Alexander
AU - Grills, Claire
AU - Halbert, Anne
AU - Lokmic, Zerina
AU - McCahon, Emma
AU - Morgan, Vanessa A.
AU - Murrell, Dedee F
AU - Orchard, David
AU - Penington, Anthony
AU - Purvis, Diana
AU - Relic, John
AU - Robertson, Susan
AU - Robinson, Aaron J.
AU - Scardamaglia, Laura
AU - Su, John
AU - Tan, Swee
AU - Wargon, Orli
AU - Warren, Lachlan
AU - Wong, Li Chuen
AU - Zappala, Tania
AU - Phillips, Roderic
PY - 2017/5
Y1 - 2017/5
N2 - Although most infantile haemangiomas do not require treatment due to a natural history of spontaneous involution, some require early intervention. The Australasian Vascular Anomalies Network and the Australasian Paediatric Dermatology Network have developed a consensus statement for the treatment of infantile haemangiomas with oral propranolol. Infants with haemangiomas that are life threatening, at risk of ulceration, or at risk of causing a significant functional impairment, psychological impact or physical deformity should be treated early with oral propranolol. Oral propranolol is safe and effective and in most healthy infants oral propranolol can be started in an outpatient setting.
AB - Although most infantile haemangiomas do not require treatment due to a natural history of spontaneous involution, some require early intervention. The Australasian Vascular Anomalies Network and the Australasian Paediatric Dermatology Network have developed a consensus statement for the treatment of infantile haemangiomas with oral propranolol. Infants with haemangiomas that are life threatening, at risk of ulceration, or at risk of causing a significant functional impairment, psychological impact or physical deformity should be treated early with oral propranolol. Oral propranolol is safe and effective and in most healthy infants oral propranolol can be started in an outpatient setting.
KW - Australian
KW - beta-blocker
KW - consensus
KW - hemangioma
KW - infantile haemangioma
KW - New Zealand
KW - propranolol
KW - vascular anomaly
UR - http://www.scopus.com/inward/record.url?scp=85014009698&partnerID=8YFLogxK
U2 - 10.1111/ajd.12600
DO - 10.1111/ajd.12600
M3 - Article
VL - 58
SP - 155
EP - 159
JO - Australasian Journal of Dermatology
JF - Australasian Journal of Dermatology
SN - 0004-8380
IS - 2
ER -